SRC Highlights

Issue 2 June 2015

Sharing our

passion

We make a difference
Larry H. from Washington, USA shares his
experience with our Wisp mask: Its made
a big difference in my life.

Become Platinum
Certified
Have you and your team members
completed the five Philips Excellence
e-modules? This training helps us all
to speak the same language and to
understand how practices like continuous
improvement can help us in our daily work.
The SRC goal for Platinum Certification is 100%. Currently,
15% of SRC associates have achieved Platinum Certification
we are only 75% from our goal. Id like to challenge all SRC
associates who are not yet Platinum Certified to complete the
training by October 31, 2015, noted John Frank, SRC Business
Group Leader.
Training modules:
Project Management Awareness
Performance Management Awareness

15% Current rate

of completion

Process Management Awareness

Continuous Improvement Awareness
Change Management Awareness

SRC Highlights - Issue 2 June 2015

100% SRC goal

Contents
3

New product introductions:

SimplyGo Mini and Trilogy EC

Our COPD story

Philips has The ANSWER

Amara View wins award

New promotional videos

for Amara View

10

New Business Solutions update

11

SRC Market news

13

Operations update

14

Employee spotlight

15

2015 Heart Walk

16

Barnes Study

17

Sleep 2015

SRC Highlights is a monthly BG

newsletter intended to educate and
inspire SRC associates by providing
relevant and interesting information
about the business and each other.
Please send us comments on what
you like about the newsletter, as
well as feedback on how we can
improve the newsletter. We are
always looking for great stuff to
share, so please send your ideas
for future news articles to:
src.communications@philips.com
2

Philips introduces
newest products:

SimplyGo Mini
and Trilogy EC
The SRC New Product Development team has been working hard to bring to
life two new product concepts.

SRC Highlights - Issue 2 June 2015

The SimplyGo Mini is Philips newest portable oxygen

concentrator (POC). At five pounds, it is the smallest and
lightest POC Philips has ever produced. Its predecessor,
SimplyGo, has consistently ranked at the top of customer
surveys as the most reliable POC available. According to
Eli Diacopoulos, Respiratory Care Business Leader, Philips
replicated design elements of the SimplyGo into the
SimplyGo Mini.
The original SimplyGo has proven to be extremely reliable,
robust and durable, says Eli It is important for us to
emphasize that the SimplyGo Mini is designed from the
same reliable architecture. So our customers DMEs and
patients have confidence that the SimplyGo Mini will
work when they need it to.
Although the new POC is designed after the original, it
does boast several unique features, including the highest
oxygen output in its class. According to Eli, SimplyGo Mini
delivers 18 percent more oxygen than its nearest lightweight
POC competitor, which means that patients have more
oxygen when they need it to sustain activities for longer
periods of time.
Lastly, SimplyGo Mini offers unsurpassed battery
performance. The unit can operate with a single or double
battery pack, allowing for a minimum of four or eight hours
of operation, respectively.
Philips targeted a select group of US customers for a May
14, 2015 soft launch of the SimplyGo Mini and will officially
roll out to the rest of the global market in July. According to
Eli, DME clients are excited about the new product and have
already expressed strong demand for the SimplyGo Mini.

SimplyGo Mini
SRC Highlights - Issue 2 June 2015

In 2009, Philips introduced the Trilogy100, a mixed-mode

portable life-support ventilator that has become the global
market leader in home ventilation. Since then, Philips has
expanded its commitment to home health care with the
addition of the Trilogy200 and innovative new therapies
like Mouth Piece Ventilation and AVAPS-AE. Mouthpiece
ventilation is a new-to-the-world therapy that helps patients
with advanced neuromuscular disease live without the need
for a tracheostomy.
In March 2015, Philips launched Trilogy EC (extended care) a
customized version of the latest model, specifically designed
for use in skilled nursing care facilities to care for patients
transitioning out of the hospital but not ready to return home.
The Trilogy EC is designed specifically for this group of
customers, says Eli Diacopoulos, Respiratory Care Business
Leader. The market needs of the institution that cares for
a ventilated patient in a skilled nursing facility or long-term
acute care facility are slightly different than that of a homeventilated patient.
According to Eli, Philips met these needs by simplifying and
disabling unnecessary modes and removing accessories from
the Trilogy EC, like the circuits and detachable battery pack,
making the Trilogy EC a competitively priced unit for Philips
target customers and helping to drive market share gains.

Trilogy EC
SRC Highlights - Issue 2 June 2015

The Trilogy EC hits a sweet spot in value and capabilities

for the skilled nursing facilities its a therapeutic-capable
ventilator without all features of the Trilogy100 that are
required for a home-ventilated patient, says Eli. And the
Trilogy100 is the perfect ventilator to send home with the
patient at discharge, since the Trilogy EC is already familiar to
the patient care team.

Our
COPD story
Philips pioneering work in chronic obstructive pulmonary disease (COPD) started several decades ago when
the company began providing health care professionals and patients with innovative treatment solutions and
services. Today, Philips is recognized as a global leader in COPD management.
Philips offers multiple products for oxygen and medication delivery,
ventilation and symptom management. A new COPD strategy one that
emphasizes a coordinated approach to managing patients suffering from
this disorder will bring together all these pieces under one broad set of
solutions, says Teofilo Lee-Chiong, M.D., Chief Medical Liaison.
This is the Philips COPD story.
Managing COPD is more than simply providing patients with respiratory
devices, says Eli Diacopoulos, Respiratory Care Business Leader. Its
about providing support across the COPD care continuum. According to
Erik Hollander, Global Marketing Leader, Philips is uniquely positioned to
do this.

We hope to increase clinical workflow efficiency and

to provide a consistent therapy experience with the
goal of reducing hospitalizations, improving clinical
outcomes, maximizing the use of medical resources
and, ultimately, enabling patients to live a more active
and fulfilling life

- Teofilo Lee-Chiong, M.D., Chief Medical Liaison

Philips is known for treating the most critically ill patients with our
ventilation and oxygen products, says Erik. But the COPD story creates
the opportunity for us to emphasize that we can help manage patients
throughout the entire course of their disease, from early stage to late
stages of COPD, because we have the solutions and expertise in place to
do so. We are simply facilitating a smoother experience.
The strategy is enabled with connected products that can remotely
monitor ventilation and oxygen therapy devices via the Philips Sapphire
project (EncoreAnywhere successor). We hope to increase clinical
workflow efficiency and to provide a consistent therapy experience
with the goal of reducing hospitalizations, improving clinical outcomes,
maximizing the use of medical resources and, ultimately, enabling
patients to live a more active and fulfilling life, says Dr. Lee-Chiong.

SRC Highlights - Issue 2 June 2015

Philips has The Answer

In February 2015, SRC launched The ANSWER, a three-step solution for DME providers to assist in managing the journey
for their sleep and COPD therapy patients. The ANSWER was carefully created to impact every touchpoint in the patient
journey, from setup through compliance and resupply.

Setup
Patient education

Adherence
Patient engagement

Support and
Resupply

System One
Nuance & Nuance Pro
Amara
Wisp
SleepMapper

Nuance & Nuance Pro

Amara
Wisp
EncoreAnywhere
SleepMapper

Philips medSage Resupply

EncoreResupply

Our goal with The ANSWER is to help our durable medical equipment (DME)
customers thrive in a difficult market, says Tony Ross, Senior Field Marketing
Manager. DMEs are experiencing a cut in reimbursements and now, more than ever,
theyre being asked to do more with less.

When customers sign up, theyre assigned a program manager who spends an entire
day with them, implementing the software and teaching the staff how to use it to their
advantage. They also work with the staff to fine-tune existing processes to be more
successful.

Philips created The ANSWER to help alleviate some of that pressure by integrating
and automating DMEs existing processes. According to Tony, the automation of this
work frees up DME staff to assist patients in more meaningful ways. It also helps to
increase patient adherence.

Having a program manager is a key advantage we have over our competitors, says
Tony. For us, its important that our customers are using the program correctly so that
they can see its advantages quickly.

The three-step solution includes the integration of patient data, automated patient
compliance and management, and the ability to differentiate with proof of improved
patient outcomes. Each solution is achieved through the use of EncoreAnywhere, a
web-based patient compliance management system, and SleepMapper, a patient
engagement tool.

SRC Highlights - Issue 2 June 2015

Since rolling out The ANSWER, Philips has received positive feedback from
participating DMEs. When the software launched in February, Tony and his team
had set a goal of enrolling 60 customers in 2015. Since launching, theyve enrolled
more than 45 customers, or more than 75 percent of the initial goal. The team is also
participating in a case study that they hope will continue to validate some initial
positive feedback.

Amara View wins the

Providers Choice Silver Award

at the Medtrade Spring Trade Show
Jim Doty (center), Senior Director, Field Marketing, North
America, showcases the Amara View minimal contact full
face mask after the product won the Providers Choice Silver
Award at Medtrade Spring

oice-Awards-and-Best-Booth&utm_term=8333315&utm_content=

For the past 3.5 years, Philips has been developing a new contender
in the full-face mask market. The result the Amara View is set to
officially launch in June with high marks following clinical testing. These
initial successes were mirrored in early April during the Medtrade Spring
Conference in Las Vegas, where the mask took home the Providers
Choice Silver Award.
This was a big win for Philips and the Amara View mask, says Jim Doty, Senior Director, Field Marketing,
North America. Our initial results show that the mask is performing well for patients in the clinical setting
and we are proud to also be recognized by our colleagues and our clients DMEs and home health
providers with this award.

This was a big win for Philips and the

Amara View mask.
- Jim Doty, Senior Director, Field Marketing, North America

SRC Highlights - Issue 2 June 2015

The Amara View is different from the traditional full-face mask in that it rests under the nose, not over it.
Amara View covers less of a patients face than any of the leading full-face masks, says Jim. Patients
can wear glasses, read or watch TV while wearing the Amara View. This makes the mask an ideal choice
for someone who may experience claustrophobia when wearing an existing full-face mask or be put off
by the red marks on the bridge of their nose.
For more than a decade, Philips has been a staple at Medtrade Fall and Medtrade Spring. As the nations
premier HME trade shows, Medtrade Fall and Medtrade Spring bring together thousands of HME
providers, home health care professionals and leading manufacturers of home health care products
and technology.

Philips addresses Conspiracy Theories in fun,

lighthearted campaign for Amara View patients
The SRC marketing team is preparing for the roll out of the
Amara View by launching a lighthearted video campaign that
pokes fun at a common side effect many users experience
while using full face sleeping masks: red irritation on the
bridge of the nose.
The video series stars Jack, a CPAP user who is constantly dispelling conspiracy
theories about how he sustained the embarrassing red mark on the bridge of his nose.
There are nine theories in total including a bad piata accident, an ill-timed high five and
a thwarted jump shot.
For this video series, we really wanted to capitalize on what sets the Amara View mask
apart in the market and thats the lack of a forehead arm, which eliminates irritation
on the bridge of the nose, says Jeff Murray, Senior Field Marketing Manager for North
America. We know this is important to patients, so we created this fun campaign to
engage them in a way that the SRC business has never attempted before.
The videos debuted at the 29th Annual Meeting of the Associated Professional Sleep
Societies in Seattle. Jeff and his team also plan to introduce Jacks conspiracy theories
to thousands of patients and clinicians via an email marketing campaign this summer.
Additional marketing includes contextual advertising and Google banner ads.
Were excited about this, says Jeff. Internally, the reception has been really good.
Assuming we get the response were looking for, we hope to refine and expand this type
of campaign for future endeavors. We hope this is just the beginning.

SRC Highlights - Issue 2 June 2015

New Business
Solutions
Philips-Genentech
partnership moves forward
Biotechnology giant Genentech, based in San Francisco,
has contracted with Philips Respironics to monitor
and analyze patients movement in order to assess
their disease state and determine the impact of their
medications. The partnership is still in its early stages
and, therefore, should not be discussed outside of Philips.
Its difficult to directly measure the state of diseases and disorders like COPD, Alzheimers, leukemia or
Parkinsons, says Mark Reed, Business Segment Director, Motion Biosensors Group. However, the way
people move, how much they move and how often they move can provide a clearer understanding of how
their disease or disorder affects them. This information, in turn, can help Genentech assess the impact of
new medications.
Philips will be supplying Genentech with wearable, motion-sensing technology, like the Actiwatch, that
Genentech will utilize to record movement information from subjects in clinical trials for multiple disease
states. Philips Respironics will then evaluate that data for new motion endpoints sensitive enough to help
Genentech, and other pharmaceutical companies, to demonstrate drug efficacy.
For some time, we have been advocates for the idea that changes in fundamental motion can provide
new endpoint measures capable of detecting therapeutic efficacy, says Mark. Genentech is the first
large pharmaceutical company to understand this concept and recognize that it is to their benefit to begin
working with us to look for these new endpoints. Were thrilled to be working with them.

SRC Highlights - Issue 2 June 2015

10

SRC Market news

During the past few months, SRC Market teams around the globe have reported big
wins, memorable moments and projects in the pipeline
ASEAN Market highlights
The Philips ASEAN Market participated in the 6th
World Congress on Sleep Medicine, held March 21-25,
2015, in Seoul, Korea. The congress brought together
sleep specialists, health care professionals and sleep
innovators from around the world to exchange ideas
and learn from each other. The Philips ASEAN market
was not only represented on the exhibit floor with a
well-designed and attractive booth, but also hosted
several events during the five-day conference.
In April, the ASEAN Market piloted events in Malaysia
aimed at connecting local physicians and clinical
workers with Philips home ventilation products and
expertise, inviting regional speakers from the South
Korea Philips Reference Site. The goal was to open
a dialogue through peer-to-peer methods, and
strengthen Philips relationship with local and national
key opinion leaders.
The events took place April 16 and 17 with topics
tailored to the target audiences. On the first day, 50
palliative clinicians and volunteers from the Motor
Neurone Disease (MND) Association completed
hands-on training with noninvasive ventilation and the
CoughAssist application in a home setting. The second
event took place the following day at Kuala Lumpurs
University of Malay Medical Center. Here, more than
120 rehab physicians, physiotherapists and nurses
collaborated to learn basic principles of pulmonary
rehabilitation, followed by a hands-on workshop.
The pilot series was so positive that the ASEAN market
leaders are exploring opportunities for additional
events in the region.

Australia Market highlights

The Australia market differs from the US market in
that manufacturers sell directly to patients. As such,
32 percent of the markets revenue comes from 19
Philips Sleepeasy centres across Australia staffed with
highly trained sleep consultants who offer education,
service and support for patients prescribed sleep and
respiratory care therapy.
Since January 2015, the market added six new
Sleepeasy locations with diagnostics partners, for a
total of 19 centres and satellite clinics resulting in 65
percent growth in revenue in Q1 2015 versus Q1 2014.

Launched a new website (Sleepsolutions.in) targeted

at physicians and patients. These efforts resulted in 15
new physicians and six diabetes specialists activated,
125 physicians trained and 750 physicians engaged.

Last October, Philips introduced SleepMapper to

Australia at the Sleep DownUnder Conference in Perth.
Since then, more than 1,000 patients have signed up
at Sleepeasy.
In April, Sleepeasy began tracking consumer feedback
using Net Promoter Score (NPS), a customer loyalty
metric used to gauge customer relationships with a
company. Consumers are rating Philips Sleepeasy with
an impressive NPS of 77.9%. The team uses this data
and any corresponding feedback to continuously
promote and improve the Sleepeasy experience.

Other important figures for the India Market include:

Sleepeasy has recently added Philips air purifiers to

their portfolio, which will offer customers improved air
quality in their homes adding to their better
breathing offering.
The Australia patient interface market saw
a 42 percent increase in revenue in Q1 2015
compared to last years first quarter, thanks to
increased sales of the popular Wisp, Nuance,
Pico and Amara Gel masks.
India Market highlights
The market is receiving excellent feedback from
physicians on Philips COPD management services

SRC Highlights - Issue 2 June 2015

for patients. Therefore, the team has begun marketing

these services for other patients, including patients
with interstitial lung and neuromuscular diseases
and those who require obesity hypoventilation and
pulmonary rehabilitation. This quarter, they have
enrolled 600 patients and six hospitals in three cities
(with plans to expand to nine cities by the end of 2015).
The efforts have generated $210,000 in revenue.

90%
share
in
government hospitals for sleep
12 new sleep labs
Largest order (34) of CoughAssist

for government hospital

R U Sleeping Pilot for screening

health checkup patients in corporate hospitals
First-time participation in cardiology conferences

roundtable meeting planned

Home Respiratory success

600 patients, rollout

planned in nine cities in 2015

11

Market news (continued)

North America Market highlights
The North American team leadership strives to
recognize members of their team who exceed
expectations. The following top performers are
examples of NA team members going above and
beyond in the market.
Gabe Ward and Tim Hutchison
Hailing from Region O, Gabe, an account manager and
Tim, a sales specialist, collaborated to enhance the
companys existing business relationship with Childrens
Hospital Homecare, the areas largest homecare
ventilation company for children.

Japan Market highlights

Japan team members have been working to launch a
website for obstructive sleep apnea (OSA) patients. The
patient activation website, Mukokyu (Sleep Apnea)
Lab, identifies potential risks related to OSA using
infographics, an OSA self-check tool, information on
how to diagnose and treat OSA and clinic and hospital
research. Since it was launched in mid-January, more
than 10,000 people have visited the site, with more
than 40 percent of visitors interested in clinic and
hospital research.

The team also represented Philips at the 79th Annual

Scientific Meeting of the Japanese Circulation Society,
held April 24-26 in Osaka. More than 18,000 people
attended the conference to learn about late-breaking
cardiovascular medicine and research in Japan. In
addition, selected Philips sales reps participated in an
advanced training course on the scientific approach
to cardiology.

Gabe put the plan into action by consulting with key

stakeholders to present each product, starting with
ventilation. Eventually, Gabe was able to present the
benefits of Trilogy to the entire Childrens staff. The
results, thanks to Tims help, included interest from key
opinion leaders and, eventually, led to product trials.
Childrens is now in the process of swapping out their
existing fleet of ventilators for Trilogy. Gabe took
ownership of the task and, with Tims support, has
been able to leverage Philips solutions and sell across
all product lines, including CoughAssist, EverFlo and
System One devices.
Gabes and Tims efforts resulted in growing Childrens
overall business from $121,000 to more than $1 million
during the past 24 months.

SRC Highlights - Issue 2 June 2015

12

Operations update
In April 2015, Philips announced the next steps in their migration toward the standard organization model for Philips
HealthTech Operations. This new model, called Organization Model 2.0 (OM2.0), allows for greater cross-business group
(BG) synergies and harmonized ways of working that will benefit the organization.
As part of the new model, Philips has introduced a new Advanced Manufacturing
organization within the SRC business group, which is led by Dave Mroz. Advanced
Manufacturing will be responsible for collaborating with Innovation to Market
(I2M) teams to ensure the successful design transfer and launch of new products;
developing manufacturing and test technologies in support of new and existing
products; making decisions on make versus buy for all products; developing the
Order to Cash (O2C) strategy; and collaborating with Group Operations to develop
industrial strategies that enable the success of the SRC business.

Murrysville, PA

Shenzhen, China

We are currently in the formation stage of our organization, says Dave. Im

excited for the opportunity to create this team in collaboration with the I2M and
Manufacturing Operations leaders to deliver an increased value to the SRC business.
The Advanced Manufacturing organization will include team members from
Murrysville, PA; Kennesaw, GA; Hong Kong; and Shenzhen, China. Existing resources
in each of these facilities will take part in the new organization to
support the BGs global needs.
Jim Lander will continue leading the Sales and Operations Planning (S&OP)
function. Jim has full ownership of the Integrated Business Planning process,
End2End Inventory process and Demand and Supply planning. In order to drive these
objectives, Jim is building supply and demand planning competencies for
the SRC businesses.
Our goal in Sales and Operations Planning is to balance customer demand with the
supply planning so that we can meet our customers needs in the most efficient and
cost-effective way, says Jim.
According to Jim, he will begin to transition those associates joining the S&OP team to
their roles over the next few months with the expectation that this organization will be
facilitating the SRC S&OP cadence in the final quarter this year.

Hong Kong
Kennesaw, GA

We will look to continue to mature the S&OP process, driving improved performance
that delivers value back to our customer, the BGs and the markets, says Jim.

SRC Highlights - Issue 2 June 2015

13

Employee spotlight

Edmund Shaw
Each month, we will be featuring an SRC team member who has demonstrated excellence in
his or her work. Our goal is two-fold: to give recognition when due and to inspire.
This month, we recognize Edmund Shaw, Senior Global Product Manager for Sleep Diagnostics, for his
leadership in strengthening the Philips sleep portfolio with the launch of Alice NightOne, a home sleep
testing device.
In the US, the diagnostic market used to consist mainly of polysomnograms, or sleep studies, which
traditionally take place in a hospital, says Edmund. But for patients who are suspected of having
obstructive sleep apnea (OSA), an at-home diagnostic device is more than sufficient. And, insurance
companies are encouraging the use of at-home testing.
In traditional sleep studies, each patient is provided a hospital room, equipment to capture data, a
dedicated sleep technologist available during the study and a skilled sleep specialist to review the data.
Polysomnograms can be labor-intensive and expensive, says Edmund. With the Alice NightOne, the
sleep specialist can confirm an OSA diagnosis and understand its severity while sparing the patient an
inconvenient and expensive hospital stay.
Edmund and his team were cautious,
however. When you give the patient
this much freedom, youre opening the
door for user error, says Edmund. To
combat this, he and his team employed
market research to determine and
eliminate possible barriers to obtaining
accurate patient data.

Edmund Shaw, Senior Global Product Manager

for Sleep Diagnostic

SRC Highlights - Issue 2 June 2015

For example, we determined through

market research that simply turning
on the device proved challenging for
33 to 90 percent of patients, says
Edmund. When we developed the Alice
NightOne, we eliminated the on button.
Now, the device activates when patients
buckle it to their chests.

Many of the Philips team members who worked

to bring Alice NightOne to market

14

2015
Heart Walk
The 2015 Heart Walk is approximately 4 months away, on Saturday, October 31 at Heinz Field in
Pittsburgh, PA. This is a big event that draws upwards of 15,000 people annually and raises over
$1M. Our goal for 2015 is to raise $50,000.
The following SRC associates are volunteering their time and leading the drive to achieve our fundraising goals this year. To easily identify these
volunteers, theyll be wearing Team Leader buttons at the office, feel free to ask them how you can be part of this exciting and rewarding event.

Heart Walk Co-Leaders:

Karen DiClaudio (CRB)
and Rhonda Johnston
(Building 286)
Team Captains:
CRB
Karen Diclaudio
Kayla Joseph
Christina Ringle
Diane Schaupp

CSF
Mary Beth Green
Ken Vandrak
RIMR
Kimberly Broker
Christine Davison
Brandy Hann
Karen Roup
Christy Wharton

Our goal is to raise $50,000 an

ambitious goal, but an achievable one.
Im counting on you to support our
fundraising efforts.

- Eli Diacopoulos, Respiratory Care Business

Leader and Executive Sponsor of the American
Heart Associations Pittsburgh Heart Walk

SRC Highlights - Issue 2 June 2015

Building 286
Eli Diacopoulos
Rhonda Johnston
Dave Myers
Youngwood
Stephanie Platts
Janet Stokum

You can help by supporting the planned

fundraising events:
Make your tax deductible donations directly at our
website, click here
Shoebox collection look for the collection box
at your location
Sarris candy sale - $1 or $2 candy bars or chocolate
covered pretzel rods
Sheetz coupon books with a $10 donation youll
receive $20 of valuable coupons
Upcoming fundraising events
Lottery ticket raffle
Golf outing tentative dates are September 12 or 13
(location to be announced)
Kickball tournament (date/location to be announced)
Major prize raffle

Philips AED valued at $1500

MacBook Air valued at $2000

Steelers game suite (6 suite tickets, 2 parking
passes and $500 cash)

Philips Sonicare Toothbrushes, Philips
Norelco Shavers, Philips Skincare System,
Philips Air Fryers and Wake Up Lights
Additional fundraising events are being planned

15

Philips Trilogy acts

as the centerpiece
of COPD patient study

More than 15 million adults in the U.S. are living with COPD and hospitals are under increasing
pressure to adhere to 30-day COPD readmissions standards. New research published in the
Journal of Clinical Sleep Medicine suggests that COPD patients who receive non-invasive
ventilation at home are less likely to be readmitted to the hospital.
The study evaluated COPD patients who were hospitalized two or more times within a year. Results showed that treating those same
patients with Philips Respironics Trilogy 100 as part of a COPD patient management program reduced readmission rates by
97 percent and resulted in a savings of more than $9 million for health insurance companies.
Barnes Health Care, a durable medical equipment company based in Georgia, developed the innovative patient management program,
which also includes nutrition counseling and information to keep patients active and help them to learn to live with their disease.
The results of this are more critical now more than ever, given the industrys increased focus on the high cost of chronic diseases and
the need to reduce the re-hospitalization of COPD patients, said Eli Diacopoulos, Respiratory Care Business Leader, Philips
Respironics. The use of Trilogy in this research is just one example of our ability to work with an innovative homecare provider partner
to achieve a new kind of COPD care management model that connects and supports the clinician, caregiver, home care provider and
the patient at every point along the patient care path.

SRC Highlights - Issue 2 June 2015

Results showed that treating

those same patients with Philips
Respironics Trilogy 100 as part
of a COPD patient management
program reduced readmission
rates by 97 percent and resulted in
a savings of more than $9 million
for health insurance companies.

16

Philips products garner

Oohs and Aahs

at SLEEP 2015
The Philips booth turned a lot of heads at this years
SLEEP 2015 conference, a joint meeting of the
American Academy of Sleep Medicine and the
Sleep Research Society.
Held in Seattle this year, SLEEP 2015 is a unique sleep
medicine event that blends together current sleep
research with the most up-to-date clinical sleep
practices. More than 5,200 physicians, researchers,
sleep technologists, students and allied health care
professionals attended the conference this year.
This year, Philips showcased a number of new products,
including the Alice NightOne, a home sleep testing
(HST) system. Alice NightOne is fully compatible with
Philips Somnolyzer scoring solution, which allows
sleep technicians to read the results from the HST to
determine an accurate sleep study score.
New patient products were also available, including
the Pico mask, which drew a nice crowd due to its small
size and ease of use, according to Mark DAngelo, Sleep
Business Leader. Conference attendees were also
impressed with the Amara View, which was available for
them to try on and experience.
Keeping in line with national trends, the Philips booth
also included two new sleep technologies designed to
streamline operations for caregivers.

(currently at +22 percent versus standard of care). Both

were well-received by attendees.
Key opinion leaders (KOLs) and staff were also invited to
a private VIP area in the center of the booth where they
were introduced to the new DREAM family of products
- DreamStation, DreamWear and DreamMapper. The
new DREAM family offers a complete range of intuitive
sleep apnea solutions designed to be as comfortable,
natural and easy to experience as sleep is intended to
be. Encouraging peace of mind and peaceful nights,
they help people to achieve the sleep they need to feel
human again, improve long term health, and rediscover
their hopes and dreams.
Our staff reported that the energy in the DREAM area
was amazing and everyone was excited about the
products, says Mark. One doctor said, I have goose
bumps! Another said, I wish I had OSA I would love to
have one of these systems!
Philips newest mask, DreamWear, received the most
attention, according to Mark.
This kind of attention confirms that were on the right
track with our DREAM products, says Mark. Now we
must complete our jobs, stay focused on the tasks at
hand and roll out the DREAM to the world.

Operational efficiencies and data at our clients

fingertips is a key component to Philips strategies,
says Mark. Our clients welcome this information with
open arms. With this in mind, we unveiled The Answer
campaign, focused on data integration and automated
patient management. We also highlighted the need
to place all patients on SleepMapper because of its
proven performance to drive positive patient outcomes

SRC Highlights - Issue 2 June 2015

17

 2015 Koninklijke Philips N.V. All rights reserved. Specifications are subject to change without notice.
Trademarks are the property of Koninklijke Philips N.V. (Royal Philips) or their respective owners.

SRC Highlights - Issue 2 June 2015

www.philips.com